121 related articles for article (PubMed ID: 26867223)
1. Late Presentation of Fulminant Necrotizing Enterocolitis in a Child with Hyperinsulinism on Octreotide Therapy.
Hawkes CP; Adzick NS; Palladino AA; De León DD
Horm Res Paediatr; 2016; 86(2):131-136. PubMed ID: 26867223
[TBL] [Abstract][Full Text] [Related]
2. Low-dose diazoxide is safe and effective in infants with transient hyperinsulinism.
Malhotra N; Yau D; Cunjamalay A; Gunasekara B; S A; Gilbert C; Morgan K; Dattani M; Dastamani A
Clin Endocrinol (Oxf); 2024 Feb; 100(2):132-137. PubMed ID: 38059644
[TBL] [Abstract][Full Text] [Related]
3. Safety of octreotide in hospitalized infants.
Testoni D; Hornik CP; Neely ML; Yang Q; McMahon AW; Clark RH; Smith PB;
Early Hum Dev; 2015 Jul; 91(7):387-92. PubMed ID: 25968047
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of octreotide treatment for diazoxide-unresponsive congenital hyperinsulinism in China.
Cao B; Di W; Su C; Chen J; Liang X; Liu M; Li W; Li X; Gong C
Pediatr Investig; 2020 Mar; 4(1):29-36. PubMed ID: 32851339
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant Alpelisib Therapy for Congenital Hyperinsulinism.
Dauleh H; Amin R; Pasha M; Hussain K
N Engl J Med; 2024 Jan; 390(4):379-380. PubMed ID: 38265652
[No Abstract] [Full Text] [Related]
6. Results of a prospective multicenter neuroendocrine tumor registry reporting on clinicopathologic characteristics of Greek patients.
Nikou GC; Pazaitou-Panayiotou K; Dimitroulopoulos D; Alexandrakis G; Papakostas P; Vaslamatzis M; Kaldrymidis P; Markussis V; Koumarianou A;
BMC Endocr Disord; 2016 Feb; 16():8. PubMed ID: 26872616
[TBL] [Abstract][Full Text] [Related]
7. Late presentation of necrotizing enterocolitis associated with rotavirus infection in a term infant with hyperinsulinism on octreotide therapy: A case report.
Alsaedi AA; Bakkar AA; Kamal NM; Althobiti JM
Medicine (Baltimore); 2017 Oct; 96(40):e7949. PubMed ID: 28984754
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of octreotide against chylothorax following lateral neck dissection for thyroid cancer: A case report.
Hayashibara N; Ogawa T; Tsuji E; Ishizuna K
Int J Surg Case Rep; 2016; 21():107-10. PubMed ID: 26963261
[TBL] [Abstract][Full Text] [Related]
9. Long-acting somatostatin analogues provide significant beneficial effect in patients with refractory small bowel angiodysplasia: Results from a proof of concept open label mono-centre trial.
Holleran G; Hall B; Breslin N; McNamara D
United European Gastroenterol J; 2016 Feb; 4(1):70-6. PubMed ID: 26966525
[TBL] [Abstract][Full Text] [Related]
10. Chylous Fistula following Axillary Lymphadenectomy: Benefit of Octreotide Treatment.
González-Sánchez-Migallón E; Aguilar-Jiménez J; García-Marín JA; Aguayo-Albasini JL
Case Rep Surg; 2016; 2016():6098019. PubMed ID: 26925285
[TBL] [Abstract][Full Text] [Related]
11. Relapsed High-Risk Medulloblastoma: Stable Disease after Two Years of Treatment with Somatostatin Analog - Case Report.
Galvis L; Gonzalez D; Bonilla C
Cureus; 2016 Jan; 8(1):e446. PubMed ID: 26918214
[TBL] [Abstract][Full Text] [Related]
12. Perspective on the Genetics and Diagnosis of Congenital Hyperinsulinism Disorders.
Stanley CA
J Clin Endocrinol Metab; 2016 Mar; 101(3):815-26. PubMed ID: 26908106
[TBL] [Abstract][Full Text] [Related]
13. Optimum dose of neostigmine to reverse shallow neuromuscular blockade with rocuronium and cisatracurium.
Choi ES; Oh AY; Seo KS; Hwang JW; Ryu JH; Koo BW; Kim BG
Anaesthesia; 2016 Apr; 71(4):443-9. PubMed ID: 26874258
[TBL] [Abstract][Full Text] [Related]
14. Acromegaly.
Dineen R; Stewart PM; Sherlock M
QJM; 2017 Jul; 110(7):411-420. PubMed ID: 26873451
[TBL] [Abstract][Full Text] [Related]
15. Involvement of M1 and CB₁ receptors in the anxiogenic-like effects induced by neostigmine injected into the rat prelimbic medial prefrontal cortex.
Fogaça MV; Fedoce AG; Ferreira-Junior NC; Guimarães FS; Resstel LB
Psychopharmacology (Berl); 2016 Apr; 233(8):1377-85. PubMed ID: 26873081
[TBL] [Abstract][Full Text] [Related]
16. Evidence that COG0325 proteins are involved in PLP homeostasis.
Prunetti L; El Yacoubi B; Schiavon CR; Kirkpatrick E; Huang L; Bailly M; El Badawi-Sidhu M; Harrison K; Gregory JF; Fiehn O; Hanson AD; de Crécy-Lagard V
Microbiology (Reading); 2016 Apr; 162(4):694-706. PubMed ID: 26872910
[TBL] [Abstract][Full Text] [Related]
17. MiR-23b targets cyclin G1 and suppresses ovarian cancer tumorigenesis and progression.
Yan J; Jiang JY; Meng XN; Xiu YL; Zong ZH
J Exp Clin Cancer Res; 2016 Feb; 35():31. PubMed ID: 26872615
[TBL] [Abstract][Full Text] [Related]
18. Plasminogen-Dependent Matriptase Activation Accelerates Plasmin Generation by Differentiating Primary Human Keratinocytes.
Chen YW; Yin S; Lai YJ; Johnson MD; Lin CY
J Invest Dermatol; 2016 Jun; 136(6):1210-1218. PubMed ID: 26872599
[TBL] [Abstract][Full Text] [Related]
19. Urokinase plasminogen activator receptor polymorphisms and airway remodelling in asthma.
Ierodiakonou D; Portelli MA; Postma DS; Koppelman GH; Gerritsen J; Ten Hacken NH; Timens W; Boezen HM; Vonk JM; Sayers I
Eur Respir J; 2016 May; 47(5):1568-71. PubMed ID: 26869673
[TBL] [Abstract][Full Text] [Related]
20. [MANAGEMENT OF THYMIC EPITHELIAL TUMORS].
Paulus A; Sibille A; Bourhaba M; Martin M; Louis R; Duysinx B
Rev Med Liege; 2015 Dec; 70(12):623-8. PubMed ID: 26867307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
